VWF and neoplasm: A fusion protein (CBD-CCL4) of chemokine CCL4 and the collagen-binding domain (CBD) of von Willebrand factor (VWF, specifically the A3 domain) was able to recruit CD103+ DCs into the TME and promote the anti-tumour immune response [200].